Gehrmann; Mathias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gehrmann; Mathias.The latest application filed is for "method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancer".

Company Profile

6.8.28

Gehrmann; Mathias - Leverkusen DE
GEHRMANN; Mathias - Cologne DE
Gehrmann; Mathias - Tonisvorst DE
Gehrmann; Mathias - Marburg DE
Gehrmann; Mathias - D-51373 Leverkusen DE
Gehrmann; Mathias - Lollar DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20220307090 - Gehrmann; Mathias ; et al.	2022-09-29
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20210123107 - DARTMANN; Mareike ; et al.	2021-04-29
Method for breast cancer recurrence prediction under endocrine treatment Grant 10,851,427 - Dartmann , et al. December 1, 2	2020-12-01
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20200224281 - DARTMANN; Mareike ; et al.	2020-07-16
Method for breast cancer recurrence prediction under endocrine treatment Grant 10,577,661 - Dartmann , et al.	2020-03-03
Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer Grant 10,301,685 - Brase , et al.	2019-05-28
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20190144949 - Gehrmann; Mathias ; et al.	2019-05-16
Method For Predicting The Benefit From Inclusion Of Taxane In A Chemotherapy Regimen In Patients With Breast Cancer App 20180135133 - Brase; Jan ; et al.	2018-05-17
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20170081728 - Gehrmann; Mathias ; et al.	2017-03-23
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20170067118 - Dartmann; Mareike ; et al.	2017-03-09
Method For Predicting The Benefit From Inclusion Of Taxane In A Chemotherapy Regimen In Patients With Breast Cancer App 20150376714 - Brase; Jan Christoph ; et al.	2015-12-31
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrentbreast Cancer App 20140228241 - Gehrmann; Mathias ; et al.	2014-08-14
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20130065786 - Dartmann; Mareike ; et al.	2013-03-14
Molecular Markers For Cancer Prognosis App 20120053842 - Gehrmann; Mathias ; et al.	2012-03-01
Prediction Of Non-fatal And Fatal Atherothrombotic Events App 20120034629 - Gehrmann; Mathias ; et al.	2012-02-09
Molecular Markers For Cancer Prognosis App 20110172928 - Gehrmann; Mathias ; et al.	2011-07-14
Algorithms For Outcome Prediction In Patients With Node-positive Chemotherapy-treated Breast Cancer App 20110166838 - Gehrmann; Mathias ; et al.	2011-07-07
Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent App 20110143946 - Gehrmann; Mathias ; et al.	2011-06-16
Liver disease-related methods and systems Grant 7,668,661 - Volker , et al. February 23, 2	2010-02-23
Methods for Breast Cancer Prognosis App 20090311700 - Gehrmann; Mathias ; et al.	2009-12-17
Prediction of Breast Cancer Response to Taxane-Based Chemotherapy App 20090239223 - Gehrmann; Mathias ; et al.	2009-09-24
Diagnosis, Prognosis and Prediction of Recurrence of Breat Cancer App 20090222387 - Gehrmann; Mathias ; et al.	2009-09-03
Monoclonal antibody and assay for detecting PIIINP Grant 7,541,149 - Burchardt , et al. June 2, 2	2009-06-02
Methods and Kits for Breast Cancer Prognosis App 20090130678 - Gehrmann; Mathias ; et al.	2009-05-21
Prediction of Breast Cancer Response to Chemotherapy App 20090069196 - Gehrmann; Mathias ; et al.	2009-03-12
Fusion proteins for prodrug activation Grant 7,273,727 - Gehrmann , et al. September 25, 2	2007-09-25
Liver disease-related methods and systems App 20070172907 - Volker; Michael ; et al.	2007-07-26
Relaxin as an independent risk factor predicting mortality App 20070166757 - Stasch; Johannes-Peter ; et al.	2007-07-19
Fusion proteins for prodrug activation App 20060292139 - Gehrmann; Mathias ; et al.	2006-12-28
Assessment of liver fibrosis scoring with serum marker algorithms Grant 7,141,380 - Volker , et al. November 28, 2	2006-11-28
Fusion proteins for prodrug activation Grant 7,060,495 - Gehrmann , et al. June 13, 2	2006-06-13
Profiling of the immune gene repertoire App 20050064421 - Gehrmann, Mathias ; et al.	2005-03-24
Assessment of liver fibrosis scoring with serum marker algorithms App 20040053242 - Volker, Michael ; et al.	2004-03-18
Fusion Proteins For Prodrug Activation App 20020068329 - GEHRMANN, MATHIAS ; et al.	2002-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.